Results for this period
Interim period (second quarter)1 October 2025–31 March 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The reactionary decline following a large electronic medical records-related project recorded in the same period of the previous year, the inability to secure highly profitable projects, a change in the manufacturer's sales policy in the GEO Solutions field, and the inability to secure a large-scale sale of a solar power plant.
There are significant events and conditions related to the going concern assumption. Although the Company has reported operating losses continuously since the fiscal year ended September 2019, there are no matters requiring disclosure in the notes regarding the going concern assumption, and the Company has determined that no material uncertainty exists at this time.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 October 2025–31 March 2026 |
| Net Sales | ¥324 million (YoY -45.0%) |
| Operating profit | ¥-257 million |
| Ordinary income | ¥-294 million |
| Profit attributable to owners of the parent | ¥-152 million |
| Net income per share | (¥11.17) |
| Equity ratio | End of the current fiscal period 59.9 / End of previous period 48.9 |
| Total assets | ¥1,806 million |
| Net assets | ¥1,115 million |
| Cash flows from operating activities | ¥-286,133 thousand |
| Cash flows from investing activities | ¥15,000 thousand |
| Cash flows from financing activities | ¥529,697 thousand |
| Cash and cash equivalents at end of period | ¥821,255 thousand |
| Full-year earnings forecast | Net Sales ¥1,377 million (YoY +59.0%) / Operating profit ¥76 million / Ordinary income ¥74 million / Net income ¥226 million |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Segment revenue | Healthcare Solutions business ¥252,983 thousand (YoY -47.2%), Global Environment Solutions Business ¥71,901 thousand (YoY -35.4%) |
| Segment profit | Healthcare Solutions business ¥-56,191 thousand, Global Environment Solutions Business ¥-12,140 thousand |
| Depreciation and amortization | ¥2,113 thousand |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on business transfer ¥149,999 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥2,950 thousand, Litigation expenses ¥2,715 thousand |
| Disclosure regarding the going concern assumption | There are significant events and conditions related to the going concern assumption. Although the Company has reported operating losses continuously since the fiscal year ended September 2019, there are no matters requiring disclosure in the notes regarding the going concern assumption, and the Company has determined that no material uncertainty exists at this time. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | The Company will reduce the amounts of its stated capital and capital surplus and carry out measures including eliminating accumulated deficits through a reduction in capital without compensation. The effective date is 26 May 2026, and no impact on net assets or financial results is expected. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | None (対象者：Not applicable) |
| Issued Shares at Period-End | 15,191,900 |
| Treasury Shares at Period-End | 74,538 |
| Factors Behind Changes in Business Performance | The reactionary decline following a large electronic medical records-related project recorded in the same period of the previous year, the inability to secure highly profitable projects, a change in the manufacturer's sales policy in the GEO Solutions field, and the inability to secure a large-scale sale of a solar power plant. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Healthcare Solutions business, the reactionary decline following a large electronic medical records-related project recorded in the same period of the previous year affected the decrease in revenue, and the business reported a loss because it was unable to secure highly profitable projects. In the Global Environmental Solutions business, revenue in the GEO Solutions field declined following a change in the manufacturer's sales policy, and the business was also unable to secure a large-scale sale of a solar power plant. In addition, the Company recorded a gain on transfer of business of ¥149.999 million from the transfer of the ONE Viewer and ONE Payment businesses.